NON-INSULIN THERAPIES FOR DIABETES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026- 2033)

Market Segmentation

• By Drug Class (Revenue, USD Bn, 2021-2033)

  • Biguanides
  • Sulfonylureas
  • Thiazolidinedione’s
  • Alpha-Glucosidase Inhibitors
  • DPP-4 Inhibitors
  • GLP-1 Analogs
  • Sodium-glucose co-transporter-2 (SGLT2) inhibitors 

• By Route Of Administration (Revenue, USD Bn, 2021-2033)

  • Oral
  • Intramuscular

• By Distribution Channel (Revenue, USD Bn, 2021-2033)

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

• By Region (Revenue, USD Bn, 2021-2033)

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa